Merck Supplement Patents Nixed In 1st Pharma AIA Reviews
The Patent Trial and Appeal Board on Friday invalidated many claims of four dietary supplement patents that Swiss Merck KgaA accused biotech firm Gnosis SpA of infringing, in what an attorney...To view the full article, register now.
Already a subscriber? Click here to view full article